Dr. Thompson joined BrightSpec in August 2020 as the Director of Business Development responsible for customer collaborations, implementation of the overall business strategy in developing markets, and interfacing with internal departments to ensure our customer needs are met.
Chris brings 17 years of industry experience working at Bruker Daltonics in Billerica, MA in the field of ultra-high resolution mass spectrometry. Initially a hardware R&D scientist, his research then focused on developing new analytical workflows and applications for FT-ICR mass spectrometry. Following these roles, he led global business development for the flagship FT-ICR MS instrument series.
During his tenure at Bruker, FT-ICR MS grew beyond a niche academic market into being the industrial standard for both MALDI Imaging and Petroleomics. Additionally, Chris helped lead the implementation of high-end mass spectrometry into the foundational areas of metabolomics/phenomics, environmental and green energy, forensics, and pharmaceutical applications ranging from small molecules to intact protein complexes.
Dr. Thompson holds a Bachelor of Science degree in both Chemistry and Mathematics from Salve Regina University, as well as a Ph.D. in Physical Chemistry from the University of Massachusetts Amherst, where he worked on the spectroscopy and dynamics of gas-phase ions with Professor Ricardo Metz.